Valeant Pharmaceuticals International Inc (NYSE:VRX)

197.48
Delayed Data
As of Feb 27
 -3.77 / -1.87%
Today’s Change
106.00
Today|||52-Week Range
204.66
+37.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line-20.3M122.6M276.7M--
 
 
 
 
Depreciation401.1M412.3M437.7M--
 
 
 
 
Total Other Cash Flow136.0M34.6M-105.7M--
 
 
 
 
Funds From Operations526.8M548.0M683.5M--
 
 
 
 
Funds From/For Other Operating Expenses42.5M167.1M66.2M--
 
 
 
 
Net Cash Flow - Operating Activities484.3M380.9M617.4M--
 
 
 
 
 
InvestingIncrease In Investments0.00-76.3M249.7K--
 
 
 
Capital Expenditures-58.1M-114.5M-39.1M--
 
 
 
 
Fixed Asset Disposal1.4M1.4M1.5B--
 
 
 
 
Net Assets From Acquisitions -306.3M-70.1M-607.0M--
 
 
 
 
Net Cash Flow Investing-384.1M-270.1M760.3M--
 
 
 
 
 
FinancingShort Term Borrowings-3.5M-3.3M122.6K--
 
 
 
 
Long Term Borrowings350.7M51.4M544.8M--
 
 
 
 
Long Term Debt Reduction-433.9M-123.5M-1.6B--
 
 
 
 
Net Proceeds Stock Sale3.5M3.6M3.8M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing1.2M6.8K15.9M--
 
 
 
 
Other Uses - Financing40.7M86.4M16.5M--
 
 
 
 
Net Cash Flow - Financing-122.7M-158.2M-1.1B--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.5M1.9M-15.3M--
 
 
 
 
 
Net Change In Cash-22.5M-47.4M293.8M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account